Translational Research in Surgical Oncology

描述(由申请者提供)：超过100万美国人将遭受 每年都会死于癌症，其中大约一半会死于 疾病。尽管在预防癌症方面做出了很大努力，但有效的早期诊断 对非转移性疾病的治疗仍然是现代 有效的癌症管理。外科手术仍然是一种主要的诊断和 癌症管理的治疗方式以及癌症治疗的进展 外科技术(如光纤和放射性核苷酸) 正常组织和病变组织的可视化及其微型化和 仪器的机器人控制)有助于改善对患者的护理 癌症患者。尽管如此，它仍然是对脑血管疾病生物学基础的理解 疾病以及癌症的有效诊断和治疗管理 在多学科的背景下，这将带来最大的进步 下一个十年。在当前的发现时代， 对外科医生进行癌症生物学基础方面的教育和培训 史无前例。肿瘤遗传学、细胞生物学和免疫学的研究进展 为基础、翻译和临床研究提供重要机会 在癌症研究方面。正如美国外科医生学院肿瘤学小组所做的那样 L加盟杜克，是加强训练的重要契机 针对外科医生的转译研究已经存在。这个教育和教育的机会 培养未来一代外科科学家和领导者提供了 这份培训补助金申请的必备条件是 外科肿瘤学中的翻译研究。

DESCRIPTION (provided by applicant): Over one million Americans will suffer from cancer every year, and approximately half of them will die from the disease. Despite major efforts to prevent cancer, effective early diagnosis and treatment of non-metastatic disease remains the hallmark of modern effective cancer management. Surgery persists as a major diagnostic and therapeutic modality for the management of cancer, and advances in the technology of surgical technique (such as fiber-optic and radio-nucleotide visualization of normal and diseased tissue and the miniaturization and robotic control of instruments) have contributed to the improved care of the cancer patient. Nonetheless, it is an understanding of the biologic basis of the disease, and the effective diagnostic and therapeutic management of cancer within a multidisciplinary context that will bring the greatest advances over the next decade. In the current era of discovery, the opportunities for the education and training of surgeons in the biologic basis of cancer is unprecedented. The advances in cancer genetics, cell biology and immunology provide important opportunities for basic, translational and clinical studies in cancer research. As the American College of Surgeons Oncology Group has r e l ocated to Duke, an important opportunity to enhance training in translational research for surgeons exists. This opportunity to educate and train future generations of surgical scientists and leaders provided a c o m pelling imperative for this application for a training grant in translational studies in surgical oncology.